|
1
|
Antoni S, Ferlay J, Soerjomataram I, Znaor
A, Jemal A and Bray F: Bladder cancer incidence and mortality: A
global overview and recent trends. Eur Urol. 71:96–108. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wirth M, Plattner VE and Gabor F:
Strategies to improve drug delivery in bladder cancer therapy.
Expert Opin Drug Deliv. 6:727–744. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liu H, Chang JK, Hou JQ, Zhao ZH and Zhang
LD: Inhibition of miR-221 influences bladder cancer cell
proliferation and apoptosis. Eur Rev Med Pharmacol Sci.
21:3193–3199. 2017.PubMed/NCBI
|
|
4
|
Akagashi K, Tanda H, Kato S, Ohnishi S,
Nakajima H, Nanbu A, Nitta T, Koroku M, Sato Y and Hanzawa T:
Recurrence pattern for superficial bladder cancer. Int J Urol.
13:686–691. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Herr HW: High-risk superficial bladder
cancer: Transurethral resection alone in selected patients with T1
tumor. Semin Urol Oncol. 15:142–146. 1997.PubMed/NCBI
|
|
6
|
Pasin E, Josephson DY, Mitra AP, Cote RJ
and Stein JP: Superficial bladder cancer: An update on etiology,
molecular development, classification, and natural history. Rev
Urol. 10:31–43. 2008.PubMed/NCBI
|
|
7
|
Masson-Lecomte A, Rava M, Real FX,
Hartmann A, Allory Y and Malats N: Inflammatory biomarkers and
bladder cancer prognosis: A systematic review. Eur Urol.
66:1078–1091. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rose TL, Deal AM, Nielsen ME, Smith AB and
Milowsky MI: Sex disparities in use of chemotherapy and survival in
patients with advanced bladder cancer. Cancer. 122:2012–2020. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yoshida T, Okuyama H, Nakayama M, Endo H,
Nonomura N, Nishimura K and Inoue M: High-dose chemotherapeutics of
intravesical chemotherapy rapidly induce mitochondrial dysfunction
in bladder cancer-derived spheroids. Cancer Sci. 106:69–77. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang J, Chen C, Wang S, Zhang Y, Yin P,
Gao Z, Xu J, Feng D, Zuo Q, Zhao R and Chen T: Bufalin inhibits
HCT116 colon cancer cells and its orthotopic xenograft tumor in
mice model through genes related to apoptotic and PTEN/AKT
pathways. Gastroenterol Res Pract. 2015:4571932015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yin PH, Liu X, Qiu YY, Cai JF, Qin JM, Zhu
HR and Li Q: Anti-tumor activity and apoptosis-regulation
mechanisms of bufalin in various cancers: New hope for cancer
patients. Asian Pac J Cancer Prev. 13:5339–5343. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yang LH, Zhang HZ, Zhang B, Chen F, Lai
ZH, Xu LF and Jin XQ: Studies on the chemical constituents from the
skin of Bufo bufo gargarizans Cantor. Yao Xue Xue Bao. 27:679–683.
1992.(In Chinese). PubMed/NCBI
|
|
13
|
Yin P, Wang Y, Qiu Y, Hou L, Liu X, Qin J,
Duan Y, Liu P, Qiu M and Li Q: Bufalin-loaded mPEG-PLGA-PLL-cRGD
nanoparticles: Preparation, cellular uptake, tissue distribution,
and anticancer activity. Int J Nanomedicine. 7:3961–3969.
2012.PubMed/NCBI
|
|
14
|
Han KQ, Huang G, Gu W, Su YH, Huang XQ and
Ling CQ: Anti-tumor activities and apoptosis-regulated mechanisms
of bufalin on the orthotopic transplantation tumor model of human
hepatocellular carcinoma in nude mice. World J Gastroenterol.
13:3374–3379. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Koh CH, Wu J, Chung YY, Liu Z, Zhang RR,
Chong K, Korzh V, Ting S, Oh S, Shim W, et al: Electronic
supplementary material identification of a Na+/K+-ATPase
inhibition-independent proarrhythmic ionic mechanisms of cardiac
glycosides. Sci Rep. 7:24652017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu M, Feng LX, Sun P, Liu W, Wu WY, Jiang
BH, Yang M, Hu LH, Guo DA and Liu X: A novel bufalin derivative
exhibited stronger apoptosis-inducing effect than bufalin in A549
lung cancer cells and lower acute toxicity in mice. PLoS One.
11:e01597892016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rao X, Huang X, Zhou Z and Lin X: An
improvement of the 2^(-delta delta CT) method for quantitative
real-time polymerase chain reaction data analysis. Biostat
Bioinforma Biomath. 3:71–85. 2013.PubMed/NCBI
|
|
18
|
Fan B, Zhang X, Ma Y and Zhang A:
Fangchinoline induces apoptosis, autophagy and energetic impairment
in bladder cancer. Cell Physiol Biochem. 43:1003–1011. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xu H, Xie L, Liu X, Zhang Y, Shen Z, Chen
T, Qiu X, Sha N, Xing C, Wu Z, et al: Impact of squamous and/or
glandular differentiation on recurrence and progression following
transurethral resection for non-muscle invasive urothelial
carcinoma of bladder. Oncol Lett. 14:3522–3528. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tran K and Severn M: Blue light cystoscopy
in patients with suspected non-muscle invasive bladder carcinoma: A
review of clinical utility [Internet]. Ottawa (ON): Canadian Agency
for Drugs and Technologies in Health; 2017
|
|
21
|
Kang KH, Han MH, Jeong JW, Park C, Lee SH,
Lee HW and Hong SH, Choi YH and Hong SH: Bufalin sensitizes human
bladder carcinoma cells to TRAIL-mediated apoptosis. Oncol Lett.
14:853–859. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang N, Xie Y, Tai Y, Gao Y, Guo W, Yu W,
Li J, Feng X, Hao J, Gao Y, et al: Bufalin inhibits hTERT
expression and colorectal cancer cell growth by targeting CPSF4.
Cell Physiol Biochem. 40:1559–1569. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Vaux DL and Korsmeyer SJ: Cell death in
development. Cell. 96:245–254. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kerr JF, Wyllie AH and Currie AR:
Apoptosis: A basic biological phenomenon with wide-ranging
implications in tissue kinetics. Br J Cancer. 26:239–257. 1972.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Arnoult D, Parone P, Martinou JC,
Antonsson B, Estaquier J and Ameisen JC: Mitochondrial release of
apoptosis-inducing factor occurs downstream of cytochrome c release
in response to several proapoptotic stimuli. J Cell Biol.
159:923–929. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liang H, Yu F, Tong Z, Yuan B and Wang C:
Effect of ischemia post-conditioning on skeletal muscle oxidative
injury, mTOR, Bax, Bcl-2 proteins expression, and HIF-1α/β-actin
mRNA, IL-6/β-actin mRNA and caveolin-3/β-actin mRNA expression in
ischemia-reperfusion rabbits. Mol Biol Rep. 40:507–514. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Qi F, Inagaki Y, Gao B, Cui X, Xu H,
Kokudo N, Li A and Tang W: Bufalin and cinobufagin induce apoptosis
of human hepatocellular carcinoma cells via Fas- and
mitochondria-mediated pathways. Cancer Sci. 102:951–958. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jiang Y, Zhang Y, Luan J, Duan H, Zhang F,
Yagasaki K and Zhang G: Effects of bufalin on the proliferation of
human lung cancer cells and its molecular mechanisms of action.
Cytotechnology. 62:573–583. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Takai N, Ueda T, Ishii T, Kira N, Nishida
M, Nishida Y, Nasu K and Narahara H: Effects of bufalin on the
proliferation of human choriocarcinoma cells. Int J Gynecol Cancer.
21:1105–1109. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang J, Sha J, Zhou Y, Han K, Wang Y, Su
Y, Yin X, Hu H and Yao Y: Bufalin inhibits proliferation and
induces apoptosis in osteosarcoma cells by downregulating
MicroRNA-221. Evid Based Complement Alternat Med. 2016:73194642016.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ren YP, Zhang MJ, Zhang T and Huang RW:
Dual effects of ouabain on the regulation of proliferation and
apoptosis in human umbilical vein endothelial cells: Involvement of
Na(+)-K(+)-ATPase α-subunits and NF-κB. Int J Clin Exp Med.
7:1214–1222. 2014.PubMed/NCBI
|
|
33
|
Kaplan JH: Biochemistry of Na,K-ATPase.
Annu Rev Biochem. 71:511–535. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mobasheri A, Avila J, Cózar-Castellano I,
Brownleader MD, Trevan M, Francis MJ, Lamb JF and Martín-Vasallo P:
Na+, K+-ATPase isozyme diversity; comparative biochemistry and
physiological implications of novel functional interactions. Biosci
Rep. 20:51–91. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Nguyen AN, Jansson K, Sánchez G, Sharma M,
Reif GA, Wallace DP and Blanco G: Ouabain activates the Na-K-ATPase
signalosome to induce autosomal dominant polycystic kidney disease
cell proliferation. Am J Physiol Renal Physiol. 301:F897–F906.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Felippe Gonçalves-de-Albuquerque C, Silva
Ribeiro A, da Silva Ignácio C, Castro-Faria-Neto Caire H and Burth
P: Na/K pump and beyond: Na/K-ATPase as a modulator of apoptosis
and autophagy. Molecules. 22:pii: E578. 2017.
|
|
37
|
Dostanic-Larson I, Lorenz JN, Van Huysse
JW, Neumann JC, Moseley AE and Lingrel JB: Physiological role of
the alpha1- and alpha2-isoforms of the Na+-K+-ATPase and biological
significance of their cardiac glycoside binding site. Am J Physiol
Regul Integr Comp Physiol. 290:R524–R528. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sakai H, Suzuki T, Maeda M, Takahashi Y,
Horikawa N, Minamimura T, Tsukada K and Takeguchi N: Up-regulation
of Na(+),K(+)-ATPase alpha 3-isoform and down-regulation of the
alpha1-isoform in human colorectal cancer. FEBS Lett. 563:151–154.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Mijatovic T, Ingrassia L, Facchini V and
Kiss R: Na+/K+-ATPase alpha subunits as new targets in anticancer
therapy. Expert Opin Ther Targets. 12:1403–1417. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kawazoe N, Aiuchi T, Masuda Y, Nakajo S
and Nakaya K: Induction of apoptosis by bufalin in human tumor
cells is associated with a change of intracellular concentration of
Na+ ions. J Biochem. 126:278–286. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Xu Y, Liu X, Schwarz S, Hu L, Guo D, Gu Q
and Schwarz W: Inhibitory efficacy of bufadienolides on Na+,K+-pump
activity versus cell proliferation. Biochem Biophys Rep. 6:158–164.
2016.PubMed/NCBI
|
